Oncology News | pharmaphorum

News

Astellas pledges $800m to Kelonia CAR-T alliance in cancer

Astellas has signed an R&D and licensing deal with Kelonia Therapeutics that aims to develop CAR-T therapies for cancer that will push the boundaries of what can be ac

News

Freenome raises $254m for cancer tests, and other financings

Our round-up of recent biotech financings is headed by a $254 million private financing for cancer blood test specialist Freenome, with sizeable rounds for Cogent Bioscien

News

Innsena backs CancerX’s digital drive to improve access

Healthtech consultancy Innsena has committed funding and expertise to The White House’s CancerX initiative, launched last year to encourage the use of digital technologies

News

Onivyde gets ‘practice-changing’ FDA OK in pancreatic cancer

Ipsen has won FDA approval for first-line use of its pancreatic cancer therapy Onivyde, saying it is now part of a potential new “standard-of-care” for patients.

News

Roche, PathAI team up on AI companion diagnostics

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and s

News

BioNTech adds CAR-T manufacturing with $250m Autolus deal

Germany’s BioNTech has taken a $200 million stake in Autolus in a private placement that will allow it to tap into the UK company’s manufacturing capacity for CAR-T therap

Astellas pledges $800m to Kelonia CAR-T alliance in cancer

Freenome raises $254m for cancer tests, and other financings

Innsena backs CancerX’s digital drive to improve access

Onivyde gets ‘practice-changing’ FDA OK in pancreatic cancer

Roche, PathAI team up on AI companion diagnostics

BioNTech adds CAR-T manufacturing with $250m Autolus deal

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

News

Editor's Picks